UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A genetic algorithm based global search strategy for population pharmacokinetic/pharmacodynamic model selection

British journal of clinical pharmacology, 2015-01, Vol.79 (1), p.28-39

2015

Volltextzugriff (PDF)

Artificial Intelligence and Pharmacometrics: Time to Embrace, Capitalize, and Advance?

CPT: pharmacometrics and systems pharmacology, 2019-07, Vol.8 (7), p.440-443

2019

Volltextzugriff (PDF)

Population pharmacokinetic modeling and simulations of berotralstat for prophylactic treatment of attacks of hereditary angioedema

Clinical and translational science, 2022-04, Vol.15 (4), p.1027-1035

2022

Volltextzugriff (PDF)

Population pharmacokinetics and exposure–response modeling for evinacumab in homozygous familial hypercholesterolemia

CPT: pharmacometrics and systems pharmacology, 2021-11, Vol.10 (11), p.1412-1421

2021

Volltextzugriff (PDF)

Assessment of Demographic and Socio-Behavioral Factors on Adherence to HIV Pre-Exposure Prophylaxis Using a Markov Modeling Approach

Frontiers in pharmacology, 2019-07, Vol.10, p.785-785

2019

Volltextzugriff (PDF)

Population Pharmacokinetics of Tenofovir in HIV-1-Uninfected Members of Serodiscordant Couples and Effect of Dose Reporting Methods

Antimicrobial agents and chemotherapy, 2016-09, Vol.60 (9), p.5379-5386

2016

Volltextzugriff (PDF)

Genetic algorithm guided population pharmacokinetic model development for simvastatin, concurrently or non-concurrently co-administered with amlodipine

Journal of clinical pharmacology, 2014-02, Vol.54 (2), p.141-149

2014

Volltextzugriff (PDF)

Subcutaneous Furosemide in Heart Failure: Pharmacokinetic Characteristics of a Newly Buffered Solution

JACC. Basic to translational science, 2018-02, Vol.3 (1), p.25-34

2018

Volltextzugriff (PDF)

Population and Noncompartmental Pharmacokinetics of Sodium Oxybate Support Weight‐Based Dosing in Children and Adolescents With Narcolepsy With Cataplexy

Clinical and translational science, 2020-09, Vol.13 (5), p.932-940

2020

Volltextzugriff (PDF)

Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis

Digestive diseases and sciences, 2015-11, Vol.60 (11), p.3408-3417

2015

Volltextzugriff (PDF)

A genetic algorithm-based, hybrid machine learning approach to model selection

Journal of pharmacokinetics and pharmacodynamics, 2006-04, Vol.33 (2), p.195-221

2006

Volltextzugriff (PDF)

Subcutaneous Furosemide in Heart Failure

JACC. Basic to translational science, 2018-02, Vol.3 (1), p.25-34

2018

Volltextzugriff (PDF)

Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy

Epilepsy research, 2003-12, Vol.57 (2), p.85-93

2003

Volltextzugriff (PDF)

A joint model for nonlinear longitudinal data with informative dropout

Journal of pharmacokinetics and pharmacodynamics, 2003-02, Vol.30 (1), p.83-103

2003

Volltextzugriff (PDF)

Abstract 3027: Application of machine learning and grid search approaches to minimize lucitanib pharmacokinetic variability following different dosing regimens

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3027-3027

2020

Volltextzugriff (PDF)

Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1−48 months

European journal of clinical pharmacology, 2010, Vol.66 (1), p.77-86

2010

Volltextzugriff (PDF)

Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building

Journal of pharmacokinetics and pharmacodynamics, 2012-08, Vol.39 (4), p.393-414

2012

Volltextzugriff (PDF)

pyDarwin: A Machine Learning Enhanced Automated Nonlinear Mixed‐Effect Model Selection Toolbox

Clinical pharmacology and therapeutics, 2024-04, Vol.115 (4), p.758-773

2024

Volltextzugriff (PDF)

Managing Immunosuppressed Patients With Inflammatory Bowel Disease During a Measles Outbreak

The American journal of gastroenterology, 2019-10, Vol.114 (10), p.1563-1565

2019

Volltextzugriff (PDF)

Development of a genetic algorithm and NONMEM workbench for automating and improving population pharmacokinetic/pharmacodynamic model selection

Journal of pharmacokinetics and pharmacodynamics, 2022-04, Vol.49 (2), p.243-256

2022

Volltextzugriff (PDF)

Pharmacokinetic Modeling and Simulations of Interaction of Amprenavir and Ritonavir

Antimicrobial Agents and Chemotherapy, 2002-03, Vol.46 (3), p.746-754

2002

Volltextzugriff (PDF)

pyDarwin machine learning algorithms application and comparison in nonlinear mixed-effect model selection and optimization

Journal of pharmacokinetics and pharmacodynamics, 2024-06

2024

Volltextzugriff (PDF)

Population Pharmacokinetic Modeling of Lucitanib in Patients with Advanced Cancer

European journal of drug metabolism and pharmacokinetics, 2022-09, Vol.47 (5), p.711-723

2022

Volltextzugriff (PDF)

Pharmacokinetic Drug–Drug Interaction Studies Between Trilaciclib and Midazolam, Metformin, Rifampin, Itraconazole, and Topotecan in Healthy Volunteers and Patients with Extensive-Stage Small-Cell Lung Cancer

Clinical drug investigation, 2022-08, Vol.42 (8), p.679-692

2022

Volltextzugriff (PDF)

The Role of Model Master Files for Sharing, Acceptance, and Communication with FDA

The AAPS journal, 2024-02, Vol.26 (2), p.28-28, Article 28

2024

Volltextzugriff (PDF)

1 – 25 von 177

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(157)
Mit Volltextzugriff
(153)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(174)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

A genetic algorithm based global search strategy for population pharmacokinetic/pharmacodynamic model selection

Artificial Intelligence and Pharmacometrics: Time to Embrace, Capitalize, and Advance?

Population pharmacokinetic modeling and simulations of berotralstat for prophylactic treatment of attacks of hereditary angioedema

Population pharmacokinetics and exposure–response modeling for evinacumab in homozygous familial hypercholesterolemia

Assessment of Demographic and Socio-Behavioral Factors on Adherence to HIV Pre-Exposure Prophylaxis Using a Markov Modeling Approach

Population Pharmacokinetics of Tenofovir in HIV-1-Uninfected Members of Serodiscordant Couples and Effect of Dose Reporting Methods

Genetic algorithm guided population pharmacokinetic model development for simvastatin, concurrently or non-concurrently co-administered with amlodipine

Subcutaneous Furosemide in Heart Failure: Pharmacokinetic Characteristics of a Newly Buffered Solution

Population and Noncompartmental Pharmacokinetics of Sodium Oxybate Support Weight‐Based Dosing in Children and Adolescents With Narcolepsy With Cataplexy

Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis

A genetic algorithm-based, hybrid machine learning approach to model selection

Subcutaneous Furosemide in Heart Failure

Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy

A joint model for nonlinear longitudinal data with informative dropout

Abstract 3027: Application of machine learning and grid search approaches to minimize lucitanib pharmacokinetic variability following different dosing regimens

Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1−48 months

Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building

pyDarwin: A Machine Learning Enhanced Automated Nonlinear Mixed‐Effect Model Selection Toolbox

Managing Immunosuppressed Patients With Inflammatory Bowel Disease During a Measles Outbreak

Development of a genetic algorithm and NONMEM workbench for automating and improving population pharmacokinetic/pharmacodynamic model selection

Pharmacokinetic Modeling and Simulations of Interaction of Amprenavir and Ritonavir

pyDarwin machine learning algorithms application and comparison in nonlinear mixed-effect model selection and optimization

Population Pharmacokinetic Modeling of Lucitanib in Patients with Advanced Cancer

Pharmacokinetic Drug–Drug Interaction Studies Between Trilaciclib and Midazolam, Metformin, Rifampin, Itraconazole, and Topotecan in Healthy Volunteers and Patients with Extensive-Stage Small-Cell Lung Cancer

The Role of Model Master Files for Sharing, Acceptance, and Communication with FDA

Suchergebnisse filtern